(Q39808939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ingrid Kockum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Lou Brundin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Lena Brundin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Finn Sellebjerg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

9

Fredrik Piehl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

10

Tomas Olsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

4

Ellen Iacobaeus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Magnus L Andersson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jan Hillert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

6 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

335-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21135023%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Elevated neurofilament levels in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Development of biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Three or more routes for leukocyte migration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Serum levels of CXCL13 are elevated in active multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Differential diagnosis of suspected multiple sclerosis: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102

Prognosis of the individual course of disease: the elements of time, hetereogeneity and precision

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510389102